File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Eyelid Myeloid Sarcoma: Ominous Presentation of Acute Myelogenous Leukemia

TitleEyelid Myeloid Sarcoma: Ominous Presentation of Acute Myelogenous Leukemia
Authors
Issue Date2015
Citation
Orbit, 2015, v. 34 n. 1, p. 30-32 How to Cite?
AbstractAbstract A 19 year-old African American man presented to our clinic for a second opinion about a right upper eyelid mass which had been recalcitrant to treatment for nonspecific orbital inflammation by an outside facility. Examination for systemic causes of the patients eyelid lesion led to a diagnosis of acute myelogenous leukemia (AML) FAB subtype M1. A subsequent biopsy of the eyelid tumor confirmed the diagnosis of a myeloid sarcoma. The patient succumbed to complications from his leukemia within 13 months of presentation. This case report is the first, to our knowledge, of an eyelid myeloid sarcoma as the presenting sign of AML and demonstrates the poor prognosis of this lesion.
Persistent Identifierhttp://hdl.handle.net/10722/205565

 

DC FieldValueLanguage
dc.contributor.authorPhelps, POen_US
dc.contributor.authorMarcet, MMen_US
dc.contributor.authorHong, ARen_US
dc.contributor.authorNichols, JWen_US
dc.date.accessioned2014-09-20T04:00:21Z-
dc.date.available2014-09-20T04:00:21Z-
dc.date.issued2015en_US
dc.identifier.citationOrbit, 2015, v. 34 n. 1, p. 30-32en_US
dc.identifier.urihttp://hdl.handle.net/10722/205565-
dc.description.abstractAbstract A 19 year-old African American man presented to our clinic for a second opinion about a right upper eyelid mass which had been recalcitrant to treatment for nonspecific orbital inflammation by an outside facility. Examination for systemic causes of the patients eyelid lesion led to a diagnosis of acute myelogenous leukemia (AML) FAB subtype M1. A subsequent biopsy of the eyelid tumor confirmed the diagnosis of a myeloid sarcoma. The patient succumbed to complications from his leukemia within 13 months of presentation. This case report is the first, to our knowledge, of an eyelid myeloid sarcoma as the presenting sign of AML and demonstrates the poor prognosis of this lesion.en_US
dc.languageengen_US
dc.relation.ispartofOrbiten_US
dc.titleEyelid Myeloid Sarcoma: Ominous Presentation of Acute Myelogenous Leukemiaen_US
dc.typeArticleen_US
dc.identifier.emailMarcet, MM: marcet@hku.hken_US
dc.identifier.authorityMarcet, MM=rp01363en_US
dc.identifier.doi10.3109/01676830.2014.938169en_US
dc.identifier.hkuros237838en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats